BCL2 and breast carcinoma: The aim of this study was to use a cohort of breast cancer cases, from the Sheffield Breast Cancer Study (SBCS) to determine whether there is a relationship between the promoter SNP rs2279115 and tumour protein levels of BCL2, and whether this corresponds to any differences in patient survival.